Dr. William Galanter, assistant professor of pharmacy at University of Illinois College of Medicine, speaks to doctors about the real cost of drug industry lunches and samples. It is time that the government looks at comparative drug efficacy. Also physicians should not have to be confronted by pharmaceutical representatives who know their prescription data. Join Host Maurie Pickard.
A Model for Processing Pharmaceutical Information
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Dr. William Galanter, assistant professor of pharmacy at University of Illinois College of Medicine, speaks to doctors about the real cost of drug industry lunches and samples. It is time that the government looks at comparative drug efficacy. Also physicians should not have to be confronted by pharmaceutical representatives who know their prescription data. Join Host Maurie Pickard.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Phase 3 study results of plozasiran in patients with FCS
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
Beyond Longevity: Discussing TAVR Durability for Women & Patients With Small Annuli
HF Management for Patients with Comorbid Conditions
Clinical Conundrums in ARIA: 1. Navigating the Baseline MRI for Anti-Aβ Monoclonal Antibodies
Clinical Conundrums in ARIA: Communicating ARIA Risk with Patients Considering Anti-Aβ Therapy
Insights on Food Allergy Anxiety: Understanding and Supporting Patients
Effect of Finerenone on NT-proBNP in HFmrEF/HFpEF: FINEARTS-HF Trial
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?